Post-exposure rabies prophylaxis: establishing effectiveness of abbreviated treatments

Several publications have reported recently the apparently successful use of human diploid cell rabies vaccine (HDCV) in volumes of less than the 6 X 1.0 cm3 dosage schedule currently recommended by the World Health Organization for post-exposure rabies prophylaxis. The newer proposed treatments are advocated to economize on an expensive product that may be available rarely in many Third World areas.